How a drug for transplant patients became known for anti-aging effect - The Washington Post
washingtonpost.comSubmitted by thewashingtonpost7104 in technology
Rapamycin, a drug for transplant patients, has extended the lives of animals but is unproven in humans. That hasn’t stopped people from trying it.